What our genes and brain scans are revealing about Parkinson’s

Scientists are getting closer to understanding how changes in our genes link to what actually happens inside the brain in Parkinson’s. A new study has combined genetic data with brain scans to find which genes are most involved in the disease and what parts of the brain they may affect. It’s helping to connect the dots between invisible DNA changes and the visible signs of Parkinson’s. Researchers looked at genetic data from thousands of people to find genes that behave differently in those with Parkinson’s. They found 74 genes whose activity seems tied to the condition. Two of them, called STX1B and HIP1R, stood out. STX1B is important for how brain cells communicate, while HIP1R helps support the brain’s wiring. These genes seem to play a role in how brain cells talk to each other and stay healthy — both areas known to go wrong in Parkinson’s. What makes this study special is that the team didn’t stop at genes. They also looked at brain scans to see where those genetic effects might show up. The results pointed to areas involved in movement — like the motor cortex — and in the white matter pathways that carry signals around the brain. In simple terms, the genes that seem most linked to Parkinson’s are also the ones that may subtly affect the parts of the brain responsible for controlling movement. This kind of work matters because it helps narrow down what’s really happening at a biological level. By knowing which genes and brain areas are involved, scientists can look for better ways to diagnose Parkinson’s early or design treatments that target the right processes. The study doesn’t give answers yet about how to stop the disease, but it offers a clearer map. It shows that Parkinson’s isn’t caused by one single fault, but by a network of small changes in how brain cells communicate, how they’re supported, and how the brain’s structure adapts over time. It’s a step toward more personalised ways of understanding and treating Parkinson’s — and that’s good news for everyone looking to the future of Parkinson’s care.